Dr. Robert Anthony Bermel, MD

Dr. Bermel practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Bermel's NPI, 1932383932, was assigned on December 27, 2007. Dr. Bermel graduated from State University of New York at Buffalo School of Medicine in 2003. Dr. Bermel holds Ohio license 090927.

Dr. Bermel's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Bermel's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Bermel to 2 more clinical labs, each named with a free account. Dr. Bermel's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bermel practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bermel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bermel is licensed in Ohio.

CMS data shows 39 Medicare services from Dr. Bermel across 3 procedure codes in 2024, for 86 Medicare patients. Medicare paid $2,561 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 86 Medicare patients who saw Dr. Bermel in 2024. The largest group is 65 to 74, with 38 patients. 66% of them have high cholesterol, and 64% have arthritis. 17% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bermel's median patient age at 49, with 70% women.

In 2024, Dr. Bermel wrote 69 Medicare Part D claims for 25 patients. 74% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $90,641 in total drug cost. In 2020, CMS named 64 claims across 3 drugs.

Dr. Bermel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bermel as offering telehealth.

CMS Open Payments shows 358 general payments to Dr. Bermel from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Genentech, Inc. paid the most, $169,520. It also lists 85 research payments totaling $49,112 from 2017 to 2025.

Dr. Bermel graduated from State University of New York at Buffalo School of Medicine in 2003.